If interim TNBC results are positive, CYDY will explode. I’m not sure how to define explode, but there will no doubt be an appreciation in SP and sharing of the results far beyond the investor community. Some may be skeptical that the results are from a small trial, but given how popular a topic breast cancer is, I still expect a decent market cap increase.

I’m not surprised that an oncologists nor a hematologist haven’t heard of leronlimab. Most doctors aren’t aware of drugs in clinical trials unless they’re involved in the trial or the drug has had positive results in a phase 3 and is pending approval. I would be skeptical as well if someone told me there’s a drug that can treat HIV, cancer, GvHD, and a number of other diseases.